Summary & Overview
CPT 88300: Surgical Pathology, Level I Specimen Examination
CPT code 88300 represents a level I surgical pathology examination, a critical service performed by pathologists to assess specimens from surgical procedures. This code covers the initial steps of specimen handling, including accessioning and gross examination, which are vital for accurate diagnosis and subsequent patient management. Nationally, this code is widely recognized and reimbursed by major payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare.
Readers will gain insight into the clinical context of 88300, its role in pathology services, and how it fits within the broader spectrum of surgical pathology codes. The publication provides benchmarks for utilization, policy updates relevant to laboratory services, and an overview of payer coverage. Understanding 88300 is important for stakeholders in laboratory medicine, billing, and healthcare policy, as it forms the basis for more complex pathology examinations and impacts reimbursement and compliance across the healthcare system.
CPT Code Overview
CPT code 88300 is used when a physician, typically a pathologist, performs a level I examination of a surgical pathology specimen. This process involves accessioning the specimen into the laboratory, which means formally receiving and documenting the specimen, followed by a gross examination of its features. The findings from this examination are then reported. The service type is Pathology, and the typical site of service is a Laboratory (Place of Service 81). This code is foundational in surgical pathology, providing essential information for clinical decision-making.
Clinical & Coding Specifications
Clinical Context
A patient presents with a skin lesion that is suspicious for malignancy or of uncertain behavior. The lesion is excised by a surgeon and sent to the laboratory for evaluation. In the laboratory (Place of Service 81), a pathologist performs a Level I examination of the surgical specimen. This involves accessioning the specimen, examining its gross features (such as size, color, and appearance), and documenting the findings. No microscopic examination is performed at this level. The pathologist reports the gross findings, which assist the clinical team in determining further management or the need for additional testing.
Coding Specifications
-
Modifier
26: Used to indicate the professional component of the service, representing the pathologist's interpretation and report. -
Modifier
TC: Used to indicate the technical component, representing the laboratory's processing and handling of the specimen.
| Modifier Code | Description |
|---|---|
26 | Professional Component |
TC | Technical Component |
- Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
207ZP0102X | Anatomic Pathology |
207ZP0101X | Clinical Pathology |
207ZP0007X | Pathology |
These taxonomies represent providers specializing in pathology, including both anatomic and clinical pathology.
Related Diagnoses
-
C44.99- Other specified malignant neoplasm of skin- Relevant for specimens where malignancy is suspected or confirmed in the skin.
-
D49.2- Neoplasm of unspecified behavior of bone, soft tissue, and skin- Used when the behavior of the neoplasm is not clearly defined, requiring further evaluation.
-
D48.5- Neoplasm of uncertain behavior of skin- Applied when the lesion's potential for malignancy is uncertain.
-
L98.9- Disorder of the skin and subcutaneous tissue, unspecified- Used for skin specimens with non-specific disorders.
-
R22.9- Localized swelling, mass and lump, unspecified- Relevant for specimens excised due to a mass or lump without a definitive diagnosis.
Each diagnosis code reflects a clinical scenario where a surgical specimen is submitted for gross examination, aligning with the use of 88300.
Related CPT Codes
-
88302- Level II - Surgical pathology, gross and microscopic examination- Used when both gross and microscopic examination are required for specimens of moderate complexity.
-
88304- Level III - Surgical pathology, gross and microscopic examination- Applied to specimens requiring more detailed gross and microscopic evaluation.
-
88305- Level IV - Surgical pathology, gross and microscopic examination- Commonly used for specimens of higher complexity, such as biopsies.
-
88307- Level V - Surgical pathology, gross and microscopic examination- Used for complex specimens, often from major organs.
-
88309- Level VI - Surgical pathology, gross and microscopic examination- Reserved for the most complex specimens, such as those requiring extensive evaluation.
These codes are related to 88300 as they represent increasing levels of complexity in surgical pathology examination. 88300 is used for gross examination only, while the others include both gross and microscopic examination. Typically, only one of these codes is used per specimen, depending on the clinical scenario.
National Reimbursement Benchmarks
Nationally, the mean rate for CPT code 88300 is $11.26 for Medicare, while the average commercial benchmark (BUCA) is slightly higher at $12.27. Blue Cross Blue Shield stands out with the highest mean rate at $14.45, whereas UnitedHealth Group and Aetna are closer to Medicare levels.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Blue Cross Blue Shield exhibits the widest spread ($7.71), indicating greater variability in contracted rates. Aetna and UnitedHealth Group have tighter ranges ($6.50 and $6.33, respectively), suggesting more consistent reimbursement levels. Cigna and Medicare also show relatively wide dispersions ($10.33 and $11.00).
The table and chart below present a detailed breakdown of national mean rates and percentile values for each payer.
State Benchmarks
State: AK1 / 51
Alaska Benchmarks
Alaska's reimbursement rates for CPT code 88300 show a wide spread among commercial payers, with Aetna at the top ($41.33 at the 75th percentile) and Cigna Health at the bottom ($7.50 at the 25th percentile). The rate spread is particularly notable for Blue Cross Blue Shield, where the difference between the 75th and 25th percentiles is $17.53, indicating substantial variability in payments. Compared to national averages, Alaska's commercial mean rates are considerably higher, with Aetna's mean rate in Alaska ($38.24) more than triple its national mean ($12.21), and similar uplifts seen across other payers.
The table and chart below present the full breakdown of mean, 25th, 50th, and 75th percentile rates for each payer in Alaska, highlighting the significant differences in reimbursement levels and the elevated payment environment relative to national benchmarks.
Key Insights for Alaska
- Aetna has the highest mean reimbursement rate for CPT 88300 in Alaska at $38.24, while Medicare is the lowest at $10.82.
- Cigna Health's mean rate is significantly below the Alaska commercial average and closely aligns with Medicare.
- All Alaska commercial payers reimburse at rates well above their respective national averages, with Aetna's mean rate more than triple its national benchmark.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.